JCN Network - Home
JCN Newswire
 Search:    Companies  | Annual Reports  |  CSR  | News Alerts  |  Japanese   
Company
News Sectors
Automotive
Chemicals
Consumers
CSR
Electronics
Energy
Environment
Financial
Health & Med
Industrial
IT & Internet
Materials
Real Estate
Science & Tech
Telecoms
Trade
Transportation
Departments
Annual Reports
Companies
Trade Shows
News Alerts
News Search
Photo Gallery
Japan Corporate News Network
About JCN
Privacy Policy
RSS  
Terms of Use
 
Bookmark and Share
Texas State U Acquires Rigaku SCXmini Chemical Crystallography Instrument for Cyber-enabled Teaching and Research
 

 Rigaku SCXmini
Tokyo, Jan 24, 2009 (JCN) - Rigaku Americas announced that the Department of Chemistry and Biochemistry at the Texas State University has purchased a Rigaku SCXmini benchtop small molecule X-ray diffraction (XRD) crystallography instrument for Cyber-enabled Small Molecule Structure Analysis for Research and Educational Purposes as funded by a Major Research Instrumentation program (MRI) grant from the National Science Foundation (NSF).

A Rigaku SCXmini X-ray crystallography system was chosen by Prof. Benjamin Martin, Principal Investigator, Prof. Gary Beall, co-PI, Prof. Michael Blanda, Co-PI, and Prof. Debra Feakes, Co-PI, to enhance the X-ray facilities of the Department of Chemistry and Biochemistry in support of education and research at Texas State and a consortium of "cyber-enabled" collaborators from Lamar University, San Antonio College, Texas Lutheran University and Sam Houston State University.

The SCXmini X-ray diffractometer will be employed to strengthen research endeavors and spark new explorations in areas involving: sulfide and selenide materials, solid state linkage isomerism and ligand substitution in transition metal cyanide complexes, conformational isomers of immobilized calix arenes, polyhedral borane anions, sulfido-bridged iron compounds and magnetostructural studies of Ni(II) dimers, and the preparation of titanium complexes as well as a variety of other research topics.

In a recent interview, Professors Martin and Beall explained that the cyber-enabled collaboration approach will enable a group of Texas institutions (which have high percentages of traditionally underrepresented student populations) to have access to single crystal X-ray diffraction for both teaching and research.

Commenting on the purchase from Rigaku's perspective, Tom McNulty, VP Materials Analysis, added that "what excites Rigaku about the SCXmini, within the context of the collaboration sponsored by Texas State, is the delivery of a broad range of experimental capabilities to a wide variety of users. Rigaku has always envisioned the SCXmini playing a key role in the education of undergraduate students and as a walk-up molecular structure tool for graduate students and postdocs."


By Saroj Shrestha Staff Writer

Copyright © 2010 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Rigaku Corporation News  RSS  
  Texas State U Acquires Rigaku SCXmini Chemical Crystallography Instrument for Cyber-enabled Teaching and Research  (Jan 24, 2009)
  Rigaku Develops Advanced High-resolution X-ray Diffraction Equipment for Lab Use  (Oct 13, 2004)
  Rigaku Builds Fast Single-Crystal X-Ray Diffraction Device  (Sept 25, 2001)



 Recent  Health/Medical News   RSS  
Asahi Kasei Integrates Bioprocess Businesses in North America (Dec 31, 2009)
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea (Nov 1, 2009)
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor (Oct 1, 2009)
New RIKEN Robot to Assist in Care Facilities (Sept 29, 2009)
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices (Sept 25, 2009)
Teijin Develops World's First Bioplastic Eyeglasses (Sept 4, 2009)
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo (Sept 4, 2009)
Kuraray Mediacal Obtains Approval for Artificial Bone Graft (Sept 2, 2009)
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania (Sept 2, 2009)
Pfizer and Astellas to Co-promote Hypertension, Hypercholesterolemia Treatment (Aug 31, 2009)

More Health/Medical news...
 
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)